Wescoe Lecture: “MIST CLINICAL TRIAL: Studying Inhaled Pirfenidone in the Treatment of Progressive Pulmonary Fibrosis (PPF)”

We’re still feeling inspired after yesterday’s incredible Wescoe Lecture Series with Dr. Lisa Lancaster—thank you for sharing your expertise with our community

But we’re not slowing down…

Our second Wescoe Lecture Series of the year is already right around the corner, and this one is one you won’t want to miss.

Join us on Tuesday, May 5th from 12–1 PM ET as we welcome Rebecca Weaver, APRN, Sr. Director of Clinical Development at Avalyn Pharma.

She’ll be diving into:

MIST Clinical Trial: Studying Inhaled Pirfenidone in the Treatment of Progressive Pulmonary Fibrosis (PPF)

This is an important conversation for patients, care partners, and healthcare professionals alike—offering insight into emerging research and what it could mean for the future of treatment.

Virtual & free to attend—just RSVP: https://buff.ly/vrsDWdK